Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
ATCC HepAD38 (HepG2 Derivative) Human Liver Cell Line, Inducible HBV Expression, Adherent, BSL-2, ~4.5x10^6 Cells/Vial
Supplier: ATCC CRL3561
HepAD38 is a human, liver-derived HepG2 derivative engineered for tetracycline-regulated (inducible) expression of the hepatitis B virus genome. It is used for antiviral compound screening and for production of encapsidated HBV DNA when expression is induced.
- Inducibly expresses the hepatitis B virus genome under tetracycline control.
- Suitable for antiviral screening and HBV DNA production.
- Adherent, epithelial-like cells derived from human liver.
- Maintain in DMEM/F12 with 10% fetal bovine serum; include tetracycline to repress expression.
- Typical vial contains approximately 4.5 x 10^6 cells; store in vapor-phase liquid nitrogen.
- Biosafety level 2 handling is recommended.
- Culture at 37°C in 95% air, 5% CO2.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?